Navigation Links
GoInformatics and TeselaGen to Partner on Scientific Data Management Solution
Date:11/15/2013

SOUTH BEND, Ind., and SAN FRANCISCO, Nov. 15, 2013 /PRNewswire-iReach/ -- GoInformatics (http://www.golims.com) and TeselaGen (http://www.teselagen.com) have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace. The cutting-edge biodesign automation tools will provide biologists the ability to engineer cells to more efficiently carry out desirable operations, such as producing medications and vaccines, better seeds and feed options, and converting plant material into high value chemicals and fuels.

Both TeselaGen and GoInformatics employ similar technology architectures that made the partnership a natural extension of each platform. GoInformatics will offer their GoLIMS platform as the infrastructure for research data collection and organization, intellectual property protection, and regulatory reporting. TeselaGen will offer its computer aided design and manufacturing platform for rapid prototyping biomolecules. The integration of GoInformatics LIMS with TeselaGen's bioCAD/CAM platform will offer clients a comprehensive set of design, manufacturing and information management tools. Ultimately, the partnership provides researchers a cost-effective, premium cloud solution for R&D informatics.

"GoInformatics' extensive experience in LIMS and ELN software solutions is a great pairing with our design automation solution," said Michael Fero, CEO, TeselaGen. "Working with our customers in medical and industrial biotechnology, TeselaGen is building the IT backbone for the emerging field of synthetic biology. Through our close collaboration with industry we have built a very economical R&D infrastructure that adds a great deal of real-world value. We think the time is ripe for all of biotech to take advantage of advanced cloud-based tools for their high-value R&D and research CRO management activities. Byte for Byte we generate some of the most valuable data in the world, encoding the next blockbuster drug or high value chemical. Having a LIMS partner like GoInformatics with a nearly identical technology stack will make integration and security provisioning a much easier proposition."

"TeselaGen's experience and capabilities in automated biomolecule design are of enormous value to our clients and prospects", said Chad Gregory, CEO, GoInformatics. "We work closely with biotech companies in RNAi therapeutics, crop science, and animal health and nutrition space where TeselaGen's bioCAD/CAM rapid prototyping tools can be of tremendous value. One of our key initiatives for this year was to find a strategic partner to compliment our product and services and bring meaningful analytical biotechnology tools to our solution set. In TeselaGen we found the ideal partner as both companies are very passionate about helping R&D organizations get more out of their spending and resources by implementing better scientific and technology infrastructures."

About GoInformatics
GoInformatics is a privately held company based in South Bend, IN. The company provides Scientific Data Management tools and services for research and development groups. GoInformatics software solutions were built from the ground up as an exclusively cloud-based technology for research collaboration and organization, intellectual property protection, and regulatory compliance. Since its official launch, GoInformatics' GoLIMS platform has been licensed and adopted by academic institutions and biotech companies around the world. The company's tools have been implemented in Agrotech, Medical Devices, and Pharmaceutical institutions in the areas of discovery, development, and investigative research.  www.golims.com

About TeselaGen
TeselaGen is a synthetic biology platform, enabling the development of viral constructs, biologic medicines, and sustainably sourced chemicals. TeselaGen is privately held and is based in San Francisco, CA. Recently founded by three former Stanford fellows and housed at the QB3 incubator at UCSF, the company has received early recognition in the form of two US National Science Foundation grants, a US Department of Energy grant and a Bio-IT World Best Practices Award. TeselaGen uses its proprietary Synthetic Evolution® technology for efficient rapid prototyping of recombinant molecules. The company's customers that are helping validate its approach include: Amgen (USA), Genomatica (USA), and Redbiotec (Switzerland). www.teselagen.com

Media Contact: Lianne Mink, GoInformatics Inc., 5743873577, press@golims.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE GoInformatics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership
3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
4. Unique Partnership Lights Up a Parkinsons Disease Research Tool
5. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
6. Ventana to partner with Incyte on the development of Companion Diagnostic tests
7. Liaison Healthcare and PointClickCare Partner for Lab Connectivity & Interoperability
8. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
9. SONIFI Healthcare And Insignia Health Partnering To Enhance Patient Engagement
10. HighPoint Solutions and InnoPeritus Partner to Provide Unprecedented Consultative Services in the European Life Sciences Market
11. ECRI Institute PSO and ISMP Partner on PSO Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2017)... 2017  Explorers Like Us ( https://explorerslikeus.com/ ) is embarking ... — and deliver these experiences as part of Life Environments™, ... and heal better. ... While nothing beats a walk, jog or simply playing ... Environments™ is the next best thing when getting there isn’t ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading ... IV infiltrations, announced it has been awarded an Innovative Technology contract ... in the country. ... monitoring device to aid in the early detection of peripheral IV ... The Innovative Technology ...
(Date:8/28/2017)... , Aug. 28, 2017   Aesculight ®, a division of ... surgical lasers. Built on over 20 years of American veterinary laser ... New and Exclusive VetScalpel®Features and Enhancements ... Duclos, DVM, is excising a tumor with his new VetScalpel laser. Dr. ... Lynnwood, WA. ...
Breaking Medicine Technology:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of ... can get while staying in compliance with FDA rules. , The FDA has ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, IL on ... industry for ensuring label quality and improving patient safety. , Microscan ...
(Date:9/21/2017)... , ... September 21, 2017 , ... FlipBelt, the fitness ... attention to detail to the athletic wear market with the launch of their FlipBelt ... can have their essentials securely at their fingertips while at the gym, on the ...
(Date:9/20/2017)... ... 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), combines strategies ... Intelligence (AI) thinking, announced today the launch of its revamped web presence. ... that offers a more comprehensive understanding of the organization’s business and machine learning ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
Breaking Medicine News(10 mins):